Dr. Debra Fadool receives grant to study mechanisms of action for cannabidiol in mouse models of anxiety

Cannabidiol (CBD) is a non-psychoactive component of cannabis that has been described for varied use such as anxiety, sleep disorder, depression, and pain - in both pets and humans. We are funded by the MMJ Consortium to use a new mouse model for anxiety and attention-like behavior deficit to uncover whether chronic CBD has potential therapeutic use to dampen or mitigate these behaviors when administered through multiple routes of delivery.